Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BY 4.0Communications Medicine

Risk of de novo immune-related adverse events in patients with cancer and autoimmune disease receiving immune checkpoint inhibitors

  • Rotana M. Radwan
  • Grant D. Scheiffele
  • Wenxi Huang
  • Aik Choon Tan
  • Todd C. Skaar
  • Lili Zhao
  • John Allen
  • Thomas J. George
  • Leng Han
  • Huda Salman
  • Jiang Bian
  • Jingchuan Guo
Open at sourceDOICite

Related

  1. Association of pre-existing cardiovascular disease with cardiovascular and clinical outcomes in patients receiving immune checkpoint inhibitors
    Lama Alfehaid, Ahmed S. Alanazi, Mansour Alomran +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. Immune checkpoint inhibitors induced autoimmune hemolytic anemia in patients with malignant cancer.
    Aoxi Liang, Yuanqiang Wu, Shengchi Chen +9
    The oncologistPeer-reviewedCC BYFull textOncologyEurope PMC
  3. The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges
    Tancredi Didier Bazan Russo, Valerio Gristina, Francesco Pepe +13
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors
    Anis Ismail, Alexi Vasbinder, Bobby Bobby +14
    JACC: CardioOncologyPeer-reviewedCC BY 4.0Full text1 citedCardiovascular medicinePMCEurope PMC
  5. 971 The impact of liver metastases on immune-related adverse events in stage IV patients treated with immune-checkpoint inhibitors: a real-world, multicenter, retrospective study
    Adil Alaoui, Jessica A Catterson, Michael B Atkins +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{radwan2026risk,
  title = {{Risk of de novo immune-related adverse events in patients with cancer and autoimmune disease receiving immune checkpoint inhibitors}},
  author = {Rotana M. Radwan and Grant D. Scheiffele and Wenxi Huang and Aik Choon Tan and Todd C. Skaar and Lili Zhao and John Allen and Thomas J. George and Leng Han and Huda Salman and Jiang Bian and Jingchuan Guo},
  journal = {Communications Medicine},
  year = {2026},
  month = nov,
  doi = {10.1038/s43856-026-01989-6},
  url = {https://www.nature.com/articles/s43856-026-01989-6},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Risk of de novo immune-related adverse events in patients with cancer and autoimmune disease receiving immune checkpoint inhibitors
AU  - Rotana M. Radwan
AU  - Grant D. Scheiffele
AU  - Wenxi Huang
AU  - Aik Choon Tan
AU  - Todd C. Skaar
AU  - Lili Zhao
AU  - John Allen
AU  - Thomas J. George
AU  - Leng Han
AU  - Huda Salman
AU  - Jiang Bian
AU  - Jingchuan Guo
PY  - 2026
DA  - 2026/11/02
JO  - Communications Medicine
DO  - 10.1038/s43856-026-01989-6
UR  - https://www.nature.com/articles/s43856-026-01989-6
SN  - 2730-664X
ER  -